Search Results - "Kurasawa, Osamu"
-
1
Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
Published in Proceedings of the National Academy of Sciences - PNAS (14-08-2018)“…General control nonderepressible 2 (GCN2) plays a major role in the cellular response to amino acid limitation. Although maintenance of amino acid homeostasis…”
Get full text
Journal Article -
2
Discovery of Novel Allosteric Inhibitors of Deoxyhypusine Synthase
Published in Journal of medicinal chemistry (26-03-2020)“…Deoxyhypusine synthase (DHPS) utilizes spermidine and NAD as cofactors to incorporate a hypusine modification into the eukaryotic translation initiation factor…”
Get full text
Journal Article -
3
Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (P-CAB)
Published in Journal of medicinal chemistry (10-05-2012)“…In our pursuit of developing a novel and potent potassium-competitive acid blocker (P-CAB), we synthesized pyrrole derivatives focusing on compounds with low…”
Get full text
Journal Article -
4
Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones
Published in Bioorganic & medicinal chemistry (01-04-2017)“…[Display omitted] Cell division cycle 7 (Cdc7) is a serine/threonine kinase that plays important roles in the regulation of DNA replication process. A genetic…”
Get full text
Journal Article -
5
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor
Published in Science advances (01-05-2019)“…Replication stress (RS) is a cancer hallmark; chemotherapeutic drugs targeting RS are widely used as treatments for various cancers. To develop next-generation…”
Get full text
Journal Article -
6
Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers
Published in Bioorganic & medicinal chemistry (15-06-2012)“…To discover a gastric antisecretory agent more potent than existing proton pump inhibitors, novel pyrrole derivatives were synthesized, and their H+,K+-ATPase…”
Get full text
Journal Article -
7
A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery
Published in Science advances (01-05-2021)“…Cell division cycle 7 (CDC7), a serine/threonine kinase, plays important roles in DNA replication. We developed a highly specific CDC7 inhibitor, TAK-931, as a…”
Get full text
Journal Article -
8
Using a biologically annotated library to analyze the anticancer mechanism of serine palmitoyl transferase (SPT) inhibitors
Published in FEBS open bio (01-04-2017)“…Mechanistic understanding is crucial to anticancer drug discovery. Here, we reveal that inhibition of serine palmitoyl transferase (SPT), the rate‐limiting…”
Get full text
Journal Article -
9
CCR5 Antagonists as Anti-HIV-1 Agents. 1. Synthesis and Biological Evaluation of 5-Oxopyrrolidine-3-carboxamide Derivatives
Published in Chemical & Pharmaceutical Bulletin (2004)“…A novel lead compound, N-{3-[4-(4-fluorobenzoyl)piperidin-1-yl]propyl}-1-methyl-5-oxo-N-phenylpyrrolidine-3-carboxamide (1), was identified as a CCR5…”
Get full text
Journal Article -
10
CCR5 antagonists as anti-HIV-1 agents. Part 2: Synthesis and biological evaluation of N-[3-(4-benzylpiperidin-1-yl)propyl]- N, N′-diphenylureas
Published in Bioorganic & medicinal chemistry (01-05-2004)“…Graphic We have previously reported the novel lead compound 1a as a CCR5 antagonist for treatment of HIV-1 infection. SAR studies on incorporating various acyl…”
Get full text
Journal Article -
11
Synthesis and Properties of Oligonucleotides Having a Phosphorus Chiral Center by Incorporation of Conformationally Rigid 5‘-Cyclouridylic Acid Derivatives
Published in Journal of organic chemistry (06-10-2000)“…This paper describes the design and synthesis of a conformationally rigid dimer building block Umpc3Um as a chiral center at the phosphate group with the S/N…”
Get full text
Journal Article -
12
Discovery of a Novel, Highly Potent, and Selective Thieno[3,2‑d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent
Published in Journal of medicinal chemistry (13-02-2020)“…In our pursuit of developing a novel, potent, and selective cell division cycle 7 (Cdc7) inhibitor, we optimized the previously reported…”
Get full text
Journal Article -
13
Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents
Published in Bioorganic & medicinal chemistry (15-05-2018)“…[Display omitted] We pursued serine palmitoyltransferase (SPT) inhibitors as novel cancer therapeutic agents based on a correlation between SPT inhibition and…”
Get full text
Journal Article -
14
New Series of Potent Allosteric Inhibitors of Deoxyhypusine Synthase
Published in ACS medicinal chemistry letters (13-08-2020)“…Deoxyhypusine synthase (DHPS) is the primary enzyme responsible for the hypusine modification and, thereby, activation of the eukaryotic translation initiation…”
Get full text
Journal Article -
15
Abstract 3073: Potential predictive biomarkers of clinical responses for a novel CDC7-selective inhibitor TAK-931
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Cell division cycle 7 (CDC7) is a serine/threonine kinase, which plays important roles in initiation of DNA replication by phosphorylating MCM2…”
Get full text
Journal Article -
16
Abstract 3847: Inhibition of GCN2 sensitizes ASNS-downregulated cancer cells to asparaginase by disrupting amino acid response
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract General control nonderepressible 2 (GCN2) plays a major role in cellular response to amino acid limitation. Although maintenance of amino acid…”
Get full text
Journal Article -
17
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode
Published in ACS medicinal chemistry letters (10-10-2019)“…General control nonderepressible 2 (GCN2) is a master regulator kinase of amino acid homeostasis and important for cancer survival in the tumor…”
Get full text
Journal Article -
18
2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase
Published in Bioorganic & medicinal chemistry (15-07-2017)“…[Display omitted] In order to increase the success rate for developing new Cdc7 inhibitors for cancer therapy, we explored a new chemotype which can comply…”
Get full text
Journal Article -
19
Synthesis and Properties of Oligodeoxynucleotides Incorporating a Conformationally Rigid Uridine Unit Having a Cyclic Structure at the 5‘-Terminal Site
Published in Journal of organic chemistry (16-06-2000)“…A 2‘-O-methyluridylic acid derivative 3 having a cyclic structure linked between the 5-position of the uracil residue and the 5‘-phosphate group was…”
Get full text
Journal Article -
20
Essential Factors for Stabilization of the Predominant C3′-endo Conformation in Dinucleoside Phosphotriester Derivatives with Cyclonucleotide Bridge Structures at the Downstream 3′-Position
Published in European journal of organic chemistry (01-05-2001)“…This paper describes the synthesis of conformationally constrained dinucleoside cyclic phosphotriester derivatives and related compounds, such as Tpc3Um (2),…”
Get full text
Journal Article